Weight changes after stopping GLP-1 drugs due to insurance
Part of Hormones & metabolism clinical trials.
This study looks at what happens to weight when people stop taking GLP-1 weight-loss drugs because their insurance no longer covers them. It may help if you're worried about regaining weight after losing coverage.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 or older.
- You are currently prescribed a weight-loss drug (like Wegovy or Ozempic) and your insurance will stop covering it soon.
- You cannot have diabetes (type 1 or type 2).
- You cannot have serious health issues like heart disease, advanced kidney disease, active cancer, or HIV/AIDS.
- You cannot be pregnant, planning pregnancy, or breastfeeding.
- You cannot smoke, use recreational drugs, or work night shifts.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study is for people who have lost weight using semaglutide or tirzepatide and are stopping that medication. It tests a stomach procedure (called mucosal ablation) to see if it can help you keep the weight off after stopping the drug.
This study follows people who recently stopped taking a GLP-1 medication (like Wegovy or Ozempic) to understand how weight, eating habits, and daily routines change over time. It aims to help patients and doctors know what to expect after stopping the drug.
This study tests whether switching to an oral weight-loss medication can help you keep off the weight you lost after stopping a GLP-1 injection like semaglutide or tirzepatide. You might qualify if you live in Massachusetts, are between 18 and 80, have a BMI of 30 or higher, lost at least 10% of your body weight on these injections, and are willing to be randomly assigned to a new treatment.
This study tests a 6-month behavioral program (including exercise, diet, and mindfulness) designed to help you keep weight off after stopping GLP-1 or similar weight-loss medications. It's for people who have already lost at least 15% of their body weight and stopped or are stopping these medications.
This study looks at what happens when people taking a GLP-1 medication (like Ozempic) either stop or continue it after weight loss surgery. The goal is to learn whether staying on the medicine helps with long-term weight control.
This study looks at how starting a GLP-1 medication (like Wegovy or Ozempic) changes your food choices and eating habits. It may help you understand if these medicines work for weight loss.
Hear when a new Obesity and Obesity-related Medical Conditions trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.